Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.

Saved in:
Bibliographic Details
Title: Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
Authors: Gottlieb M; Department of Emergency Medicine, Rush University Medical Center, Chicago, Illinois, USA., Wang RC; Department of Emergency Medicine, University of California, San Francisco, California, USA., Yu H; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Spatz ES; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA., Montoy JCC; Department of Emergency Medicine, University of California, San Francisco, California, USA., Rodriguez RM; Department of Emergency Medicine, University of California - San Francisco School of Medicine, San Francisco, California, USA., Chang AM; Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Elmore JG; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California, USA., Hannikainen PA; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Hill M; Department of Emergency Medicine, UTHealth Houston, Houston, Texas, USA., Huebinger RM; Department of Emergency Medicine, UTHealth Houston, Houston, Texas, USA., Idris AH; Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Lin Z; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Koo K; Department of Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, USA., McDonald S; Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Clinical Informatics Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA., O'Laughlin KN; Department of Global Health, University of Washington, Seattle, Washington, USA., Plumb ID; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Santangelo M; Department of Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, USA., Saydah S; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Willis M; Department of Global Health, University of Washington, Seattle, Washington, USA., Wisk LE; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California, USA., Venkatesh A; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Stephens KA; Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA., Weinstein RA; Department of Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, USA.; Department of Medicine, Division of Infectious Diseases, Cook County Hospital, Chicago, Illinois, USA.
Corporate Authors: Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jun 08; Vol. 76 (11), pp. 1930-1941.
Publication Type: Multicenter Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciad045